Loading...
Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide
[Image: see text] Chidamide is a histone deacetylase (HDAC) inhibitor that is currently used to treat cutaneous T-cell lymphoma in clinic. Herein nicotinamide phosphoribosyltransferase (NAMPT) was identified to be a new target of chidamide on the basis of the pharmacophore analysis, molecular dockin...
Na minha lista:
| Udgivet i: | ACS Med Chem Lett |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American
Chemical
Society
2019
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956351/ https://ncbi.nlm.nih.gov/pubmed/31938461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.9b00407 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|